Laxmipriya Nampoothiri

Prof. Laxmipriya Nampoothiri


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
MRMaharjan H. Radha
Maharjan H. Radha
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
Aloe vera ( lú huì) is well known for its considerable medicinal properties. This plant is one of the richest natural sources of health for human beings coming. The chemistry of the plant has revealed the presence of more than 200 different biologically active substances. Many biological properties associated with Aloe species are contributed by inner gel of the leaves. Most research has been centralized on the biological activities of the various species of Aloe, which include antibacterial and antimicrobial activities of the nonvolatile constituents of the leaf gel. Aloe species are widely distributed in the African and the eastern European continents, and are spread almost throughout the world. The genus Aloe has more than 400 species but few, such as A. vera, Aloe ferox, and Aloe arborescens, are globally used for trade. A. vera has various medicinal properties such as antitumor, antiarthritic, antirheumatoid, anticancer, and antidiabetic properties. In addition, A. vera has also been promoted for constipation, gastrointestinal disorders, and for immune system deficiencies. However, not much convincing information is available on properties of the gel. The present review focuses on the detailed composition of Aloe gel, its various phytocomponents having various biological properties that help to improve health and prevent disease conditions.

11 April 2018 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
NCNirja Chaudhari
Nirja Chaudhari
MDMitali Dawalbhakta
Mitali Dawalbhakta
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
GnRH is the master molecule of reproduction that is influenced by several intrinsic and extrinsic factors such as neurotransmitters and neuropeptides. Any alteration in these regulatory loops may result in reproductive-endocrine dysfunction such as the polycystic ovarian syndrome (PCOS). Although low dopaminergic tone has been associated with PCOS, the role of neurotransmitters in PCOS remains unknown. The present study was therefore aimed at understanding the status of GnRH regulatory neurotransmitters to decipher the neuroendocrine pathology in PCOS. PCOS was induced in rats by oral administration of letrozole (aromatase inhibitor). Following PCOS validation, animals were assessed for gonadotropin levels and their mRNA expression. Neurotrasnmitter status was evaluated by estimating their levels, their metabolism and their receptor expression in hypothalamus, pituitary, hippocampus and frontal cortex of PCOS rat model. We demonstrate that GnRH and LH inhibitory neurotransmitters – serotonin, dopamine, GABA and acetylcholine – are reduced while glutamate, a major stimulator of GnRH and LH release, is increased in the PCOS condition. Concomitant changes were observed for neurotransmitter metabolising enzymes and their receptors as well. Our results reveal that increased GnRH and LH pulsatility in PCOS condition likely result from the cumulative effect of altered GnRH stimulatory and inhibitory neurotransmitters in hypothalamic-pituitary centre. This, we hypothesise, is responsible for the depression and anxiety-like mood disorders commonly seen in PCOS women.

20 September 2011 in Andrologia
Verified
Journal Article
Closed access
PDF file
CPC. Pandya
C. Pandya
PPP. Pillai
P. Pillai
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
NBN. Bhatt
N. Bhatt
SGSarita Gupta
Sarita Gupta

1 January 2010 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
RMRadha Maharjan
Radha Maharjan
PNPadamnabhiS Nagar
PadamnabhiS Nagar
This is a preliminary study that explores the efficacy of Aloe vera gel formulation as a possible therapeutic agent in the prevention and management of polycystic ovary syndrome (PCOS). PCOS is recognized as the most common endocrinopathy of women. Increased androgen synthesis, disrupted folliculogenesis, and insulin resistance lie at the patho-physiological core of PCOS. Current therapy for such a syndrome is use of insulin sensitizers. Large randomized clinical trials of metformin as the insulin-sensitizing drug, however, suggested that it produces many side effects after prolonged usage. For this reason, an alternate therapy would be to use herbs with hypoglycemic potential. Aloe barbadensis Mill. (Liliaceae) popularly known as Aloe vera is a well-known plant with such properties. The present study evaluated the efficacy of Aloe vera gel formulation in a PCOS rat model. Five month old Charles Foster female rats were orally fed with letrozole, a non-steroidal aromatase inhibitor, to induce PCOS. The rats were then treated orally with the Aloe vera gel formulation (1 ml dose daily for 45 days). This restored their estrus cyclicity, glucose sensitivity, and steroidogenic activity. Co-treatment of the inductive agent (letrozole) with the Aloe vera gel prevented the development of the PCO phenotype. Aloe vera gel formulation exerts a protective effect in against the PCOS phenotype by restoring the ovarian steroid status, and altering key steroidogenic activity. This can be attributed to phyto-components present in the extract.

3 August 2006 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
AAAvnika Agarwal
Avnika Agarwal
SGSarita Gupta
Sarita Gupta

1 February 2006 in Reproductive Toxicology
Verified
Journal Article
Closed access
LNLaxmipriya Nampoothiri
Laxmipriya Nampoothiri
SGSarita Gupta
Sarita Gupta